These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30209123)

  • 1. Digoxin and clinical outcomes in the Global Rheumatic Heart Disease Registry.
    Karthikeyan G; Devasenapathy N; Zühlke L; Engel ME; Rangarajan S; Teo KK; Mayosi BM; Yusuf S;
    Heart; 2019 Mar; 105(5):363-369. PubMed ID: 30209123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF-TIMI 48 Trial.
    Eisen A; Ruff CT; Braunwald E; Hamershock RA; Lewis BS; Hassager C; Chao TF; Le Heuzey JY; Mercuri M; Rutman H; Antman EM; Giugliano RP
    J Am Heart Assoc; 2017 Jun; 6(7):. PubMed ID: 28666993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Digoxin on Mortality in Patients With Atrial Fibrillation Stratified by Heart Failure: Findings From Gulf Survey of Atrial Fibrillation Events in the Middle East.
    Al-Zakwani I; Panduranga P; Zubaid M; Sulaiman K; Rashed WA; Alsheikh-Ali AA; AlMahmeed W; Shehab A; Al Qudaimi A; Asaad N; Amin H
    J Cardiovasc Pharmacol Ther; 2016 May; 21(3):273-9. PubMed ID: 26341119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of digoxin use in atrial fibrillation and the risk of all-cause mortality in patients ≥65 years of age with versus without heart failure.
    Shah M; Avgil Tsadok M; Jackevicius CA; Essebag V; Behlouli H; Pilote L
    Am J Cardiol; 2014 Aug; 114(3):401-6. PubMed ID: 24950677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of digoxin and risk of death or readmission for heart failure and sinus rhythm: A nationwide propensity score matched study.
    Madelaire C; Schou M; Nelveg-Kristensen KE; Schmiegelow M; Torp-Pedersen C; Gustafsson F; Køber L; Gislason G
    Int J Cardiol; 2016 Oct; 221():944-50. PubMed ID: 27441473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of digoxin on risk of death in heart failure patients treated with b-blockers. Results from Polish part of ESC Heart Failure Long-Term Registry.
    Migaj J; Kałużna-Oleksy M; Nessler J; Opolski G; Crespo-Leiro MG; Maggioni AP; Grajek S; Ponikowski P; Drożdż J; Straburzyńska-Migaj E
    Kardiol Pol; 2018; 76(7):1064-1072. PubMed ID: 29476617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality in heart failure with atrial fibrillation: Role of digoxin and diuretics.
    Gonzalez-Loyola F; Abellana R; Verdú-Rotellar JM; Bustamante Rangel A; Clua-Espuny JL; Muñoz MA
    Eur J Clin Invest; 2018 Nov; 48(11):e13014. PubMed ID: 30091171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of digoxin use and risk of mortality in ED patients with atrial fibrillation.
    Wu S; Yang YM; Zhu J; Ren JM; Wang J; Zhang H; Shao XH
    Am J Emerg Med; 2017 Nov; 35(11):1589-1594. PubMed ID: 28551087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digoxin Impact on Heart Failure Patients with Atrial Fibrillation.
    Gerakaris A; Mulita F; Koniari I; Artopoulou E; Mplani V; Tsigkas G; Abo-Elseoud M; Kounis N; Velissaris D
    Med Arch; 2022 Feb; 76(1):23-28. PubMed ID: 35422570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial.
    Gheorghiade M; Fonarow GC; van Veldhuisen DJ; Cleland JG; Butler J; Epstein AE; Patel K; Aban IB; Aronow WS; Anker SD; Ahmed A
    Eur Heart J; 2013 May; 34(20):1489-97. PubMed ID: 23592708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digoxin and Mortality in Patients With Atrial Fibrillation.
    Lopes RD; Rordorf R; De Ferrari GM; Leonardi S; Thomas L; Wojdyla DM; Ridefelt P; Lawrence JH; De Caterina R; Vinereanu D; Hanna M; Flaker G; Al-Khatib SM; Hohnloser SH; Alexander JH; Granger CB; Wallentin L;
    J Am Coll Cardiol; 2018 Mar; 71(10):1063-1074. PubMed ID: 29519345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digoxin Initiation and Outcomes in Patients with Heart Failure (HFrEF and HFpEF) and Atrial Fibrillation.
    Singh S; Moore H; Karasik PE; Lam PH; Wopperer S; Arundel C; Tummala L; Anker MS; Faselis C; Deedwania P; Morgan CJ; Zeng Q; Allman RM; Fonarow GC; Ahmed A
    Am J Med; 2020 Dec; 133(12):1460-1470. PubMed ID: 32603789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digoxin and mortality in atrial fibrillation: a prospective cohort study.
    Hallberg P; Lindbäck J; Lindahl B; Stenestrand U; Melhus H;
    Eur J Clin Pharmacol; 2007 Oct; 63(10):959-71. PubMed ID: 17684738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
    Sethi NJ; Nielsen EE; Safi S; Feinberg J; Gluud C; Jakobsen JC
    PLoS One; 2018; 13(3):e0193924. PubMed ID: 29518134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Digoxin Use Among Medicaid Enrollees With Atrial Fibrillation.
    Adedinsewo D; Xu J; Agasthi P; Oderinde A; Adekeye O; Sachdeva R; Rust G; Onwuanyi A
    Circ Arrhythm Electrophysiol; 2017 May; 10(5):e004573. PubMed ID: 28500174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy of beta-blockers and digoxin is associated with increased risk of major adverse cardiovascular events and all-cause mortality in patients with atrial fibrillation: a report from the GLORIA-AF registry.
    Lam SHM; Romiti GF; Olshansky B; Chao TF; Huisman MV; Lip GYH
    Intern Emerg Med; 2024 Aug; 19(5):1369-1378. PubMed ID: 38780748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of renin-angiotensin system inhibitors on long-term clinical outcomes of patients with rheumatic heart disease.
    Liu C; Lai Y; Wu D; Fu R; Li Y; Li H; Guan T; Shen Y
    ESC Heart Fail; 2021 Dec; 8(6):5338-5351. PubMed ID: 34545695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digoxin Is Associated With Increased All-cause Mortality in Patients With Atrial Fibrillation Regardless of Concomitant Heart Failure: A Meta-analysis.
    Wang ZQ; Zhang R; Chen MT; Wang QS; Zhang Y; Huang XH; Wang J; Yan JH; Li YG
    J Cardiovasc Pharmacol; 2015 Sep; 66(3):270-5. PubMed ID: 26348825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort.
    Allen LA; Fonarow GC; Simon DN; Thomas LE; Marzec LN; Pokorney SD; Gersh BJ; Go AS; Hylek EM; Kowey PR; Mahaffey KW; Chang P; Peterson ED; Piccini JP;
    J Am Coll Cardiol; 2015 Jun; 65(25):2691-8. PubMed ID: 26112191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data.
    Ziff OJ; Lane DA; Samra M; Griffith M; Kirchhof P; Lip GY; Steeds RP; Townend J; Kotecha D
    BMJ; 2015 Aug; 351():h4451. PubMed ID: 26321114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.